If you are already taking phentermine and wondering whether semaglutide could be added to your plan, or if you are on a GLP-1 program and curious about phentermine for additional support, this guide covers what the current evidence shows, who may qualify, and what risks to discuss with your provider before making any changes
Potential endpoints include: Protein kinase activation Transcription-factor activity Gene-expression changes Cellular copper-associated variables Enzyme-expression patterns Secreted protein measurements Cell viability Time-dependent signaling changes A signaling change is a mechanistic observation and does not independently establish improved tissue function
By this time, the medication has a more pronounced effect on appetite suppression, improved metabolism, and reduced calorie intake
Adding baseline blood pressure, fasting blood glucose, and if accessible, a lipid panel gives you the metabolic markers to track alongside the scale